Background: Currently, we lack a clear picture of the evolution of major depressive disorder (MDD) in adolescents. The period of disturbance preceding MDD can be conceptualised as the prodrome. The aim of the study was to explore the prodrome of first-episode MDD retrospectively in a group of help-seeking adolescents using qualitative methodologies. Sampling and Methods: Consecutively referred adolescents (15-18 years of age) with first-episode MDD were recruited for this study from Orygen Youth Health, Melbourne, Vic., Australia. After using quantitative methodologies to confirm the index episode of MDD and measure the extent of recovery, the prodrome was investigated in depth using qualitative techniques. Results: Twenty-nine adolescents (20 females and 9 males) and 7 informants (6 mothers and 1 grandmother) participated. All 29 participants had a prodrome of varying lengths (between 6 days and 4 years). The most noticeable symptoms initially were perplexity and confusion and, thereafter, sadness and irritability. A common pattern was a reduction in their ability to fulfil their role accompanied by guilt, self-blame and reduced self-esteem. Around half of the participants had increased thoughts of suicide and increased anxiety. There were gender differences in the patterns of symptoms noticed, with males more commonly noticing a change in how they related to the world and females more commonly noticing a change in the way that they related to others. All informants noticed a prodrome of varying lengths; in 2 cases longer, in 2 cases shorter and in 3 cases around the same time period as that noticed by the participant. The changes most commonly noticed by informants were sadness, upset, irritability and reduced self-esteem. The symptoms were fewer in number and sometimes varied from those noticed by the adolescents themselves. Conclusions: Whilst we recognise that this study is vulnerable to autobiographical bias, we took all reasonable measures to minimise this. Symptoms not included in the diagnostic criteria for depression were the earliest changes noticed by the adolescents themselves and are, therefore, potentially important in informing prevention strategies, as is the finding that there are gender differences in the patterns of changes noticed. In addition, parents may provide an additional avenue to help seeking.

Keywords:
Prodrome, Qualitative research methodology, Depression, Adolescent
1.
Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, de Graaf R, Demyttenaere K, Hu C, Iwata N, Karam AN, Kaur J, Kostyuchenko S, Lepine JP, Levinson D, Matschinger H, Mora ME, Browne MO, Posada-Villa J, Viana MC, Williams DR, Kessler RC: Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011;9:90.
2.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry 2005;62:593-602.
3.
Brent DA, Weersing VR: Depressive disorders in childhood and adolescence; in Rutter M, Bishop D, Pine D, Scott S, Stevenson JS, Taylor E, Thapar A (eds): Rutter's Child and Adolescent Psychiatry. Oxford, Blackwell Publishing, 2008, pp 587-612.
4.
Lewinsohn PM, Rohde P, Klein DN, Seeley JR: Natural course of adolescent major depressive disorder: I. Continuity into young adulthood. J Am Acad Child Adolesc Psychiatry 1999;38:56-63.
5.
Cuijpers P, van Straten A, Smit F, Mihalopoulos C, Beekman A: Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions. Am J Psychiatry 2008;165:1272-1280.
6.
Merry SN, Hetrick SE, Cox GR, Brudevold-Iversen T, Bir JJ, McDowell H: Psychological and educational interventions for preventing depression in children and adolescents. Cochrane Database Syst Rev 2011:CD003380.
7.
Fava GA, Grandi S, Canestrari R, Molnar G: Prodromal symptoms in primary major depressive disorder. J Affect Disord 1990;19:149-152.
8.
Fava GA, Tossani E: Prodromal stage of major depression. Early Interv Psychiatry 2007;1:9-18.
9.
Hetrick SE, Parker AG, Hickie IB, Purcell R, Yung AR, McGorry PD: Early identification and intervention in depressive disorders: towards a clinical staging model. Psychother Psychosom 2008;77:263-270.
10.
Kovacs M, Lopez-Duran N: Prodromal symptoms and atypical affectivity as predictors of major depression in juveniles: implications for prevention. J Child Psychol Psychiatry 2010;51:472-496.
11.
Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD: Psychosis prediction: 12-month follow up of a high-risk (‘prodromal') group. Schizophr Res 2003;60:21-32.
12.
Fava GA, Kellner R: Prodromal symptoms in affective disorders. Am J Psychiatry 1991;148:823-830.
13.
Yung AR, Woods SW, Ruhrmann S, Addington J, Schultze-Lutter F, Cornblatt BA, Amminger GP, Bechdolf A, Birchwood M, Borgwardt S, Cannon TD, de Haan L, French P, Fusar-Poli P, Keshavan M, Klosterkotter J, Kwon JS, McGorry PD, McGuire P, Mizuno M, Morrison AP, Riecher-Rossler A, Salokangas RK, Seidman LJ, Suzuki M, Valmaggia L, van der Gaag M, Wood SJ, McGlashan TH: Whither the attenuated psychosis syndrome? Schizophr Bull 2012;38:1130-1134.
14.
Howes OD, Lim S, Theologos G, Yung AR, Goodwin GM, McGuire P: A comprehensive review and model of putative prodromal features of bipolar affective disorder. Psychol Med 2011;41:1567-1577.
15.
Jackson A, Cavanagh J, Scott J: A systematic review of manic and depressive prodromes. J Affect Disord 2003;74:209-217.
16.
McGorry PD, Purcell R, Goldstone S, Amminger GP: Age of onset and timing of treatment for mental and substance use disorders: implications for preventive intervention strategies and models of care. Curr Opin Psychiatry 2011;24:301-306.
17.
Lewinsohn PM, Solomon A, Seeley JR, Zeiss A: Clinical implications of ‘subthreshold' depressive symptoms. J Abnorm Psychol 2000;109:345-351.
18.
Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A: Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 1996;22:283-303.
19.
Syed RJ, Yung AR: Research protocol. Rev Colomb Psiquiatr 2006;35:144-149.
20.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
21.
Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas 1977;1:385-401.
22.
First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders. New York, Biometrics Research, New York State Psychiatric Institute, 1997.
23.
Kessler RC, Avenevoli S, Ries Merikangas K: Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry 2001;49:1002-1014.
24.
Georgiades K, Lewinsohn PM, Monroe SM, Seeley JR: Major depressive disorder in adolescence: the role of subthreshold symptoms. J Am Acad Child Adolesc Psychiatry 2006;45:936-944.
25.
Ialongo NS, Edelsohn G, Kellam SG: A further look at the prognostic power of young children's reports of depressed mood and feelings. Child Dev 2001;72:736-747.
26.
Keenan K, Hipwell A, Feng X, Babinski D, Hinze A, Rischall M, Henneberger A: Subthreshold symptoms of depression in preadolescent girls are stable and predictive of depressive disorders. J Am Acad Child Adolesc Psychiatry 2008;47:1433-1442.
27.
Bertha EA, Balazs J: Subthreshold depression in adolescence: a systematic review. Eur Child Adolesc Psychiatry 2013;22:589-603.
28.
Shankman SA, Lewinsohn PM, Klein DN, Small JW, Seeley JR, Altman SE: Subthreshold conditions as precursors for full syndrome disorders: a 15-year longitudinal study of multiple diagnostic classes. J Child Psychol Psychiatry 2009;50:1485-1494.
29.
Wesselhoeft R, Sorensen MJ, Heiervang ER, Bilenberg N: Subthreshold depression in children and adolescents: a systematic review. J Affect Disord 2013;151:7-22.
30.
Chaplin TM, Gillham JE, Seligman ME: Gender, anxiety, and depressive symptoms: a longitudinal study of early adolescents. J Early Adolesc 2009;29:307-327.
31.
Zahn-Waxler C, Klimes-Dougan B, Slattery MJ: Internalizing problems of childhood and adolescence: prospects, pitfalls, and progress in understanding the development of anxiety and depression. Dev Psychopathol 2000;12:443-466.
32.
Balazs J, Miklosi M, Kereszteny A, Hoven CW, Carli V, Wasserman C, Apter A, Bobes J, Brunner R, Cosman D, Cotter P, Haring C, Iosue M, Kaess M, Kahn JP, Keeley H, Marusic D, Postuvan V, Resch F, Saiz PA, Sisask M, Snir A, Tubiana A, Varnik A, Sarchiapone M, Wasserman D: Adolescent subthreshold-depression and anxiety: psychopathology, functional impairment and increased suicide risk. J Child Psychol Psychiatry 2013;54:670-677.
33.
Angst J, Sellaro R, Merikangas KR: Depressive spectrum diagnoses. Compr Psychiatry 2000;41:39-47.
34.
Cantwell DP, Lewinsohn PM, Rohde P, Seeley JR: Correspondence between adolescent report and parent report of psychiatric diagnostic data. J Am Acad Child Adolesc Psychiatry 1997;36:610-619.
35.
Costello EJ, Farmer EM, Angold A, Burns BJ, Erkanli A: Psychiatric disorders among American Indian and white youth in Appalachia: the Great Smoky Mountains study. Am J Public Health 1997;87:827-832.
36.
Marton P, Churchard M, Kutcher S: Cognitive distortion in depressed adolescents. J Psychiatry Neurosci 1993;18:103-107.
37.
Clarke GN, Hawkins W, Murphy M, Sheeber LB, Lewinsohn PM, Seeley JR: Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of a group cognitive intervention. J Am Acad Child Adolesc Psychiatry 1995;34:312-321.
38.
Gillham JE, Hamilton J, Freres DR, Patton K, Gallop R: Preventing depression among early adolescents in the primary care setting: a randomized controlled study of the Penn Resiliency Program. J Abnorm Child Psychol 2006;34:203-219.
39.
Young JF, Mufson L, Davies M: Efficacy of interpersonal psychotherapy-adolescent skills training: an indicated preventive intervention for depression. J Child Psychol Psychiatry 2006;47:1254-1262.
40.
McGorry PD, Nelson B, Goldstone S, Yung AR: Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Can J Psychiatry 2010;55:486-497.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.